FDA 483 - SSM-SLUH, Inc. - February 17, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of SSM-SLUH, Inc., a hospital blood bank in Saint Louis, MO, revealed significant deficiencies in quality control and adherence to standard operating procedures. The firm failed to maintain adequate validation records for automated processes and did not properly investigate unexplained discrepancies related to emergency blood releases. Additionally, employees did not consistently follow written procedures for blood component processing and storage, and equipment validation plans were found to be inadequate.
ID · 14b19afa-6c22-4821-bcb1-f2181e8db1dc